BG Medicine says it will work with the Copenhagen General Population Study to discover and validate novel proteomic biomarkers linked to myocardial infarction. The CGPS collaboration is part of the High-Risk Plaque Initiative, a four-year, $30 million research effort launched a year ago to develop better methods and technologies that can identify individuals at risk for heart disease. Specifically, the initiative is aimed at improving the understanding and management of high-risk plaque, which is closely associated with heart attacks and stroke.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.